Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00345384 · ClinicalTrials.gov registry record · Phase 1
Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients
A Phase 1 study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT00345384 is a Phase 1 study that has completed, run by Baylor Research Institute. The registered enrollment target is 38 participants.
The verdict
NCT00345384, a Phase 1 study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, efficacy, hemodynamic and respiratory stability of a low-dose of dexmedetomidine infusion in post-operative surgical in-patients undergoing thoracic surgery after discharge from PACU or ICU.
Interventions
- DRUG Dexmedetomidine
- OTHER Placebo (Normal Saline)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00345384
The ClinicalTrials.gov registry entry for NCT00345384 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT00345384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00345384 about?
NCT00345384 is a clinical study titled "Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients". The purpose of this study is to evaluate the safety, efficacy, hemodynamic and respiratory stability of a low-dose of dexmedetomidine infusion in post-operative surgical in-patients undergoing thoracic surgery after discharge from PACU or ICU.
What is the current status of trial NCT00345384?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2008-05. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00345384?
The interventions under investigation include: Dexmedetomidine (DRUG), Placebo (Normal Saline) (OTHER).
Who is sponsoring clinical trial NCT00345384?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.